Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Industry Eyes DPP-4, GLP-1 Data From Diabetes Meeting

Jun 05 2008

• By Pamela Taulbee

Related Content

Liraglutide Up For Approval In U.S. And Europe

May 23 2008

Merck Revises Guidance To Include $700 Million Less In Vytorin/Zetia Sales

Apr 21 2008

Bristol Eyes 2008 NDA For DPP-4 Inhibitor Saxagliptin

Dec 27 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window